Kusajili – Clinical trials directory

A phase 3 study to determine the efficacy and safety of recombinant human activated protein C in severe sepsis Not provided at time of registration

• Country Belgium, Canada, France, Spain, United States,
• organs None
• Specialty None

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma (NHL): a phase III randomised clinical trial (Intergroup Collaborative Study) Not provided at time of registration

• Country Australia, Belgium, Canada, Denmark, Egypt, France, Hungary, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Slovenia, South Africa, Sweden, Switzerland, United Kingdom,
• organs None
• Specialty None

Evaluation of Acetyl-L-Carnitine (ST 200) to reduce intensity of taxanes- or platinum-induced sensory neuropathy Not provided at time of registration

• Country Belgium, France, Italy,
• organs None
• Specialty None

Evaluation of a new pre-heparinised filter: a multicentre, open, prospective pilot study Not provided at time of registration

• Country Belgium, France,
• organs None
• Specialty None